☰

David Reisman - Publications

Affiliations: 
University of South Carolina, Columbia, SC 
Area:
gene expression, DNA damage, p53 tumor suppressor
Tree Info Similar researchers PubMed Report error

19 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2021 Moxley AH, Reisman D. Context is key: Understanding the regulation, functional control, and activities of the p53 tumour suppressor. Cell Biochemistry and Function. 39: 235-247. PMID 32996618 DOI: 10.1002/cbf.3590  0.657
2016 Luo H, Shenoy AK, Li X, Jin Y, Jin L, Cai Q, Tang M, Liu Y, Chen H, Reisman D, Wu L, Seto E, Qiu Y, Dou Y, Casero RA, et al. MOF Acetylates the Histone Demethylase LSD1 to Suppress Epithelial-to-Mesenchymal Transition. Cell Reports. PMID 27292636 DOI: 10.1016/J.Celrep.2016.05.050  0.339
2014 Marquez SB, Thompson KW, Lu L, Reisman D. Beyond Mutations: Additional Mechanisms and Implications of SWI/SNF Complex Inactivation. Frontiers in Oncology. 4: 372. PMID 25774356 DOI: 10.3389/fonc.2014.00372  0.301
2014 Kahali B, Yu J, Marquez SB, Thompson KW, Liang SY, Lu L, Reisman D. The silencing of the SWI/SNF subunit and anticancer gene BRM in Rhabdoid tumors. Oncotarget. 5: 3316-32. PMID 24913006 DOI: 10.18632/Oncotarget.1945  0.333
2014 Polson A, Reisman D. The bidirectional p53-Wrap53β promoter is controlled by common cis- and trans-regulatory elements. Gene. 538: 138-49. PMID 24418698 DOI: 10.1016/j.gene.2013.12.046  0.816
2012 Reisman D, Takahashi P, Polson A, Boggs K. Transcriptional Regulation of the p53 Tumor Suppressor Gene in S-Phase of the Cell-Cycle and the Cellular Response to DNA Damage. Biochemistry Research International. 2012: 808934. PMID 22830025 DOI: 10.1155/2012/808934  0.691
2012 Kothandapani A, Gopalakrishnan K, Kahali B, Reisman D, Patrick SM. Downregulation of SWI/SNF chromatin remodeling factor subunits modulates cisplatin cytotoxicity. Experimental Cell Research. 318: 1973-86. PMID 22721696 DOI: 10.1016/j.yexcr.2012.06.011  0.4
2011 Polson A, Durrett E, Reisman D. A bidirectional promoter reporter vector for the analysis of the p53/WDR79 dual regulatory element. Plasmid. 66: 169-79. PMID 21924287 DOI: 10.1016/j.plasmid.2011.08.004  0.788
2011 Takahashi P, Polson A, Reisman D. Elevated transcription of the p53 gene in early S-phase leads to a rapid DNA-damage response during S-phase of the cell cycle. Apoptosis : An International Journal On Programmed Cell Death. 16: 950-8. PMID 21710255 DOI: 10.1007/s10495-011-0623-z  0.731
2010 Polson A, Takahashi P, Reisman D. ChIP (chromatin immunoprecipitation) analysis demonstrates co-ordinated binding of two transcription factors to the promoter of the p53 tumour-suppressor gene. Cell Biology International. 34: 883-91. PMID 20446924 DOI: 10.1042/CBI20090401  0.728
2009 Becker TM, Haferkamp S, Dijkstra MK, Scurr LL, Frausto M, Diefenbach E, Scolyer RA, Reisman DN, Mann GJ, Kefford RF, Rizos H. The chromatin remodelling factor BRG1 is a novel binding partner of the tumor suppressor p16INK4a Molecular Cancer. 8. PMID 19149898 DOI: 10.1186/1476-4598-8-4  0.405
2009 Boggs K, Henderson B, Reisman D. RBP-Jkappa binds to and represses transcription of the p53 tumor suppressor gene. Cell Biology International. 33: 318-24. PMID 19135161 DOI: 10.1016/j.cellbi.2008.12.005  0.858
2007 Reisman D, Boggs K. Transcriptional regulation of the p53 tumor suppressor gene: a potential target for cancer therapeutics? Recent Patents On Dna & Gene Sequences. 1: 176-85. PMID 19075931 DOI: 10.2174/187221507782360236  0.853
2007 Boggs K, Reisman D. C/EBPbeta participates in regulating transcription of the p53 gene in response to mitogen stimulation. The Journal of Biological Chemistry. 282: 7982-90. PMID 17244625 DOI: 10.1074/jbc.M611675200  0.855
2006 Thomas S, Reisman D. Localization of a mutant p53 response element on the tissue inhibitor of metalloproteinase-3 promoter: mutant p53 activities are distinct from wild-type. Cancer Letters. 240: 48-59. PMID 16236433 DOI: 10.1016/j.canlet.2005.08.027  0.501
2004 Reisman D, McFadden JW, Lu G. Loss of heterozygosity and p53 expression in Pterygium. Cancer Letters. 206: 77-83. PMID 15019163 DOI: 10.1016/j.canlet.2003.10.026  0.577
2002 Betz BL, Strobeck MW, Reisman DN, Knudsen ES, Weissman BE. Re-expression of hSNF5/INI1/BAF47 in pediatric tumor cells leads to G1 arrest associated with induction of p16ink4a and activation of RB. Oncogene. 21: 5193-203. PMID 12149641 DOI: 10.1038/Sj.Onc.1205706  0.368
2002 Reisman DN, Strobeck MW, Betz BL, Sciariotta J, Funkhouser W, Murchardt C, Yaniv M, Sherman LS, Knudsen ES, Weissman BE. Concomitant down-regulation of BRM and BRG1 in human tumor cell lines: differential effects on RB-mediated growth arrest vs CD44 expression. Oncogene. 21: 1196-207. PMID 11850839 DOI: 10.1038/sj.onc.1205188  0.368
2002 Strobeck MW, Reisman DN, Gunawardena RW, Betz BL, Angus SP, Knudsen KE, Kowalik TF, Weissman BE, Knudsen ES. Compensation of BRG-1 function by Brm: insight into the role of the core SWI-SNF subunits in retinoblastoma tumor suppressor signaling. The Journal of Biological Chemistry. 277: 4782-9. PMID 11719516 DOI: 10.1074/Jbc.M109532200  0.303
Show low-probability matches.